Welcome to our dedicated page for Churchill Capital X SEC filings (Ticker: CCCXU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Churchill Capital Corp X (CCCXU) provides direct access to the company’s regulatory disclosures as a Nasdaq-listed blank check company. Churchill X files reports with the U.S. Securities and Exchange Commission that describe its SPAC structure, unit composition, governance changes and its proposed business combination with ColdQuanta, Inc. (Infleqtion).
Key documents for CCCXU include Current Reports on Form 8-K that outline material events. For example, a Form 8-K dated July 2, 2025 details the commencement of separate trading for the units, Class A ordinary shares (CCCX) and warrants (CCCXW), including the warrant exercise terms. Another Form 8-K dated September 8, 2025 summarizes the Agreement and Plan of Merger and Reorganization with Infleqtion, the planned domestication from the Cayman Islands to Delaware, the intended name change to "Infleqtion, Inc." and the conditions required to close the Transactions.
Through this page, users can review Churchill X’s registration statement on Form S-4 and related proxy statement/prospectus once filed and declared effective. These filings explain the proposed issuance of securities in the business combination, shareholder voting matters, risk factors and detailed descriptions of Infleqtion’s business. Additional filings may include periodic reports and further 8-Ks documenting board changes, director compensation agreements and other governance matters.
Stock Titan enhances access to these filings with AI-powered tools that summarize lengthy documents, highlight key sections such as transaction structure, closing conditions and dilution mechanics, and help users quickly locate information on unit terms, warrant features and the domestication process. Investors can also use this page to monitor any future Forms 4 or other ownership-related filings that may be associated with Churchill X’s directors, officers or sponsor entities as they are reported to EDGAR in real time.
Infleqtion, Inc. filed a Form 3 showing that investor Tyler Brous is a more than 10% beneficial owner of INFQ. The filing reports a stock option for 34,740 shares held directly; this option becomes fully exercisable only when a Form S-8 registration statement for Infleqtion becomes effective, which cannot occur before April 14, 2026.
Common shares are held indirectly through affiliated entities LCP Quantum Partners I–VI. These entities hold 14,363,414; 3,097,848; 7,796,419; 1,814,502; 2,816,731; and 640,000 Infleqtion common shares, respectively. Brous has or shares voting and investment power over these securities through related management LLCs but disclaims beneficial ownership except to the extent of his pecuniary interest.
Infleqtion, Inc. Schedule 13G discloses that Tyler Brous and affiliated LCP Quantum entities beneficially own 30,563,654 shares of Common Stock, equal to 14.1% of the class. The filing shows shared voting and dispositive power of 30,563,614 shares and notes Mr. Brous holds options exercisable for 34,740 shares. The reporting persons state they are filing jointly and expressly disclaim membership in a group. The signatures are dated
Infleqtion, Inc. reports Schedule 13G disclosures showing shared beneficial ownership stakes by Global Frontier entities and W. Grant Dollens. Global Frontier Investments, LLC (GFI) has 25,622,170 shares (11.84%); Global Frontier Quantum Opportunity Fund (GFQOF) holds 20,839,094 shares (9.63%); W. Grant Dollens is reported with 25,705,546 shares (11.87%). These percentages are calculated based on 216,471,927 shares outstanding as of
The filing states shared voting and dispositive power for the Global Frontier entities and indicates GFQOF holds its shares for the benefit of its investors.
Infleqtion, Inc. has a new large shareholder group, as Maverick-affiliated funds filed a Schedule 13D reporting beneficial ownership of 19,976,664 common shares, or 9.2% of the company. The percentage is based on 216,471,927 shares outstanding, including options for 34,740 shares.
The Maverick entities and principals Lee S. Ainslie III and David B. Singer state they hold the position for investment purposes, funded with working capital from various Maverick funds. They may buy more or sell shares over time, and may discuss Infleqtion’s strategy and ways to maximize stockholder value with management and other stakeholders, but currently report no specific plans for major corporate actions.
Churchill Capital Corp X/Cayman received an initial Form 3 from investment adviser Maverick Capital and related reporting persons, detailing their indirect holdings of the company’s common stock and options as of February 13, 2026. The filing lists several large blocks of common stock held through Maverick-managed funds and accounts, including holdings of 9,816,912 shares and 6,217,382 shares, along with additional smaller positions in other vehicles. It also reports stock option positions labeled as a right to buy, with 34,740 and 29,950 options outstanding, tied to director compensation for David B. Singer. One third of the shares underlying these options vest on February 17, 2027, with the remainder vesting monthly thereafter, and the economic benefit of this director compensation is directed to a Maverick-related fund. Each reporting owner disclaims beneficial ownership beyond its or his pecuniary interest.
Infleqtion, Inc. director David B. Singer reported receiving two grants of stock options totaling 64,690 options. One block of 34,740 fully vested options reflects legacy ColdQuanta, Inc. awards that were automatically converted into Infleqtion options in connection with the Churchill Capital Corp X–ColdQuanta mergers and subsequent name change to Infleqtion, Inc.
The second grant covers 29,950 options tied to his board service, with one-third vesting on February 17, 2027 and the remainder vesting monthly over three years, subject to continued service. The economic benefit of his director compensation flows to Maverick Ventures Investment Fund, L.P. through a management fee offset, and Singer disclaims beneficial ownership except to the extent of his pecuniary interest.
Churchill Capital Corp X/Cayman director reports option grant tied to merger. Dawn Clawson Meyerriecks acquired stock options for 347,403 shares of Infleqtion, Inc. on February 13, 2026, at an exercise price of $0.00 per share. These options are fully vested and were received under a merger agreement dated September 8, 2025, in which Churchill Capital Corp X combined with ColdQuanta, Inc. and changed its name to Infleqtion, Inc. Legacy ColdQuanta stock options were automatically converted into options of Infleqtion with the same terms and conditions.
Infleqtion, Inc. director Kristina M. Johnson reported equity awards linked to the merger of Churchill Capital Corp X with ColdQuanta. She was granted 373,458 stock options at an exercise price of
Johnson also reported an acquisition of 33,120 shares of common stock for
Churchill Capital Corp X/Cayman director James Eric Bjornholt reported an option grant. He acquired a stock option covering 29,950 shares of the company’s stock. According to the vesting terms, one-third of the option vests on February 17, 2027, and the remaining shares vest in equal monthly installments over the following three years, conditioned on his continued service.
Catherine P. Lego, a director of Infleqtion, Inc. (formerly Churchill Capital Corp X), reported stock awards tied to the company’s merger with ColdQuanta, Inc. She acquired 477,680 shares of common stock directly and 82,801 shares indirectly through Lego Holdings, LP as merger consideration.
Footnotes state these shares were issued upon conversion of the Company’s Series C-1 preferred stock in the completed merger structure. Of the reported shares, 103,739 are subject to Infleqtion’s right of repurchase and vest monthly in equal installments until December 10, 2026, contingent on her continued service.